Do Craniopharyngioma Molecular Signatures Correlate with Clinical Characteristics?

Introduction: Exome sequencing studies have recently demonstrated that papillary (C-PAP) and adamantinomatous craniopharyngiomas (aCP) have distinct genetic origins, each primarily driven by mutually exclusive alterations either BRAF (V600 E), observed in 95% of C-PAP or CTNNB1, observed in 75 - 96% of aCP. How these molecular signatures, or their absence, correlate with clinical, radiographic and outcome variables is unknown.

Methods: The pathology records were reviewed from May 2000 to March 2015 at Weill Cornell Medical College and craniopharyngiomas were identified and classified as C-PAP or aCP. Patients were grouped under 3 genomic mutation types: BRAF mutation only, CTNNB1 mutation only, tumors with none of these mutations detected (Not Detected). Demographic data, presenting symptoms, age, extent of resection, recurrence were correlated with genetic mutations.

Results: Histology correlated strongly with mutation group. All BRAF mutated tumors were C-PAP, All CTNNB1 and all Not Detected tumors were aCP. Pre- and post-operative clinical symptoms and radiographic features did not correlate with any mutation group. However, patients with no mutations (Not Detected) were more likely to be pediatric (p = 0.022) and have tumors in the sella (p = 0.008). Extent of resection complications and recurrence did not correlate with mutation group.

Conclusion: Craniopharyngioma mutation signature is highly predictive of histology. The subgroup of tumors with no detected mutations are more likely pediatric, located in the sella and of aCP histology.

 

MissingLinkText

Die Autoren geben an, dass kein Interessenkonflikt besteht.